69 related articles for article (PubMed ID: 37981104)
1. The Dichotomy of Interleukin-9 Function in the Tumor Microenvironment.
Cannon A; Pajulas A; Kaplan MH; Zhang J
J Interferon Cytokine Res; 2023 Jun; 43(6):229-245. PubMed ID: 37319357
[TBL] [Abstract][Full Text] [Related]
2. The "Heater" of "Cold" Tumors-Blocking IL-6.
Pu W; Ma C; Wang B; Zhu W; Chen H
Adv Biol (Weinh); 2024 May; ():e2300587. PubMed ID: 38773937
[TBL] [Abstract][Full Text] [Related]
3. IL-1 Family Members in Bone Sarcomas.
Landuzzi L; Ruzzi F; Pellegrini E; Lollini PL; Scotlandi K; Manara MC
Cells; 2024 Jan; 13(3):. PubMed ID: 38334625
[TBL] [Abstract][Full Text] [Related]
4. Chimeric antigen receptor T-cells targeting IL-1RAP: a promising new cellular immunotherapy to treat acute myeloid leukemia.
Trad R; Warda W; Alcazer V; Neto da Rocha M; Berceanu A; Nicod C; Haderbache R; Roussel X; Desbrosses Y; Daguindau E; Renosi F; Roumier C; Bouquet L; Biichle S; Guiot M; Seffar E; Caillot D; Depil S; Robinet E; Salma Y; Deconinck E; Deschamps M; Ferrand C
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35803613
[TBL] [Abstract][Full Text] [Related]
5. Overcoming target epitope masking resistance that can occur on low-antigen-expresser AML blasts after IL-1RAP chimeric antigen receptor T cell therapy using the inducible caspase 9 suicide gene safety switch.
Warda W; Da Rocha MN; Trad R; Haderbache R; Salma Y; Bouquet L; Roussel X; Nicod C; Deschamps M; Ferrand C
Cancer Gene Ther; 2021 Dec; 28(12):1365-1375. PubMed ID: 33414517
[TBL] [Abstract][Full Text] [Related]
6. CAR-T cells targeting IL-1RAP produced in a closed semiautomatic system are ready for the first phase I clinical investigation in humans.
Nicod C; da Rocha MN; Warda W; Roussel X; Haderbache R; Seffar E; Trad R; Bouquet L; Goncalves M; Bosdure L; Laude MC; Guiot M; Ferrand C; Deschamps M
Curr Res Transl Med; 2023; 71(2):103385. PubMed ID: 36773434
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor accessory protein (IL-1RAP): A magic bullet candidate for immunotherapy of human malignancies.
Zarezadeh Mehrabadi A; Shahba F; Khorramdelazad H; Aghamohammadi N; Karimi M; Bagherzadeh K; Khoshmirsafa M; Massoumi R; Falak R
Crit Rev Oncol Hematol; 2024 Jan; 193():104200. PubMed ID: 37981104
[TBL] [Abstract][Full Text] [Related]
8. The roles of interleukin-1 receptor accessory protein in certain inflammatory conditions.
Zarezadeh Mehrabadi A; Aghamohamadi N; Khoshmirsafa M; Aghamajidi A; Pilehforoshha M; Massoumi R; Falak R
Immunology; 2022 May; 166(1):38-46. PubMed ID: 35231129
[TBL] [Abstract][Full Text] [Related]
9. IL-1RAP, a Key Therapeutic Target in Cancer.
Frenay J; Bellaye PS; Oudot A; Helbling A; Petitot C; Ferrand C; Collin B; Dias AMM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499246
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
